capsensixx AG

  • WKN: A2G9M1
  • ISIN: DE000A2G9M17
  • Land: Deutschland

Nachricht vom 03.06.2019 | 09:30

capsensixx AG: capsensixx subsidiary Oaklet successfully expands corporate structures

DGAP-News: capsensixx AG / Key word(s): Personnel

03.06.2019 / 09:30
The issuer is solely responsible for the content of this announcement.

capsensixx subsidiary Oaklet successfully expands corporate structures

Frankfurt, 03 June 2019 - Oaklet GmbH, subsidiary of capsensixx AG (ISIN DE000A2G9M17), continues to expand its team in Luxembourg. After onboarding new employees for the Frankfurt site at the end of the first quarter, Erik van Os (46) joined Oaklet S.A. based in Luxembourg on 01st of June to develop the Group's comprehensive range of services within its segment Capital Markets & Corporate Services.

Most recently, Mr. van Os worked for The Bank of New York Mellon SA / NV, Luxembourg Branch, where he served as Head of Corporate Trusts, leading a team of specialists for operational (Registrar, Paying and Transfer Agent, Listing Agent, Custody and Account Bank Services), regulatory and legal matters. Previously, he worked in the structured finance department at Deutsche Bank Luxembourg S.A. and at TMF Group in several countries.

Oaklet began expanding its business services in 2018 to include so-called "third-party providers" and is continuing to expand its corporate structures. The expanded range of services matches with brisk demand in the market.

Sven Ulbrich, CEO of Oaklet's parental company capsensixx: "We are pleased to welcome Erik van Os, another well-proven expert and highly motivated colleagues for our team who brings fresh momentum and a great structuring experience. To further drive organic growth, Oaklet will continue to expand its workforce. "

Klaudius Sosnik, Chairman of the Board of Oaklet S.A., adds: "With Erik van Os, we did not only manage to hire a respected expert in our industry. Rather, we will be able to further benefit from his ideas and know-how in the expansion of the service offering in the "Third-Party" division. One of the growth drivers is an increased demand for securitization of so-called ESG investments. With his post graduate diploma in "Islamic Banking and Finance", van Os optimally strengthens the existing expertise in the company. "

About capsensixx
capsensixx manages, structures and executes financial products in various asset classes and product workflows in the financial sector for its customers (Financial Administration as a Service). The business model, which focuses on funds and alternative assets, is characterized by a high proportion of recurring income and profitable growth. The subsidiaries Axxion (capital management) and Oaklet (specialist for securitization and other financial services) have a very strong position on the German-speaking market in these two areas. The technology start-up coraixx is involved in digitizing financial receipts using artificial intelligence, thus expanding capsensixx' value chain and developing new areas of business and customer groups with high growth potential.

You can find further information on

Media Relations:
edicto GmbH
Axel Mühlhaus / Dr. med. Sönke Knop
Telephone: +49 (0) 69 905505-52

03.06.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this


HELMA Eigenheimbau: Klarer Kauf

Die HELMA Eigenheimbau hat mit dem Zugang weiterer Ferienimmobilienprojekte das potenzielle Umsatzvolumen um 150 Mio. € gesteigert. Ohnehin verfügt die Gesellschaft über einen umfangreichen Grundstücksbestand für das Bauträgergeschäft, womit in den kommenden Geschäftsjahren Umsätze in Höhe von über 1,4 Mrd. € realisiert werden könnten. Damit dürften unsere Schätzungen, in denen wir ein nachhaltiges Überschreiten der Umsatzmarke von 300 Mio. € annehmen, gut unterfüttert sein. Bei einem Kursziel von 65,00 € ist die HELMA-Aktie ein klarer Kauf.

News im Fokus

Fresenius Medical Care erreicht Ziele für Geschäftsjahr 2019 und bestätigt Ausblick 2020 auf nachhaltiges profitables Wachstum

19. Februar 2020, 20:58

Aktuelle Research-Studie SE

Original-Research: SE (von Montega AG): Halten

20. Februar 2020